SCHEMBL25663152

SCHEMBL25663152

c1ccc2nc(-c3ccc(N(c4ccc(-c5ncc6ccccc6n5)cc4)c4ccc5cc(-c6ncnc7c6sc6ccccc67)ccc5c4)cc3)ncc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.42
▸ LIMK1 P53667 4/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ PIK3CA P42336 3/20 0.34
▸ PIK3CD O00329 2/20 0.34
▸ PIK3CB P42338 2/20 0.34
▸ MTOR P42345 2/20 0.34
▸ PIK3CG P48736 2/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ EGFR P00533 4/20 0.32
▸ CHEK2 O96017 1/20 0.32
▸ FLT1 P17948 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663153 0.86 NPC1 (0.38) LIMK1CDK5CDK5R1PIK3CAPIK3CD
SCHEMBL25663158 0.84 LIMK1 (0.37) LIMK1CDK5CDK5R1PIK3CAPIK3CD
SCHEMBL25663155 0.83 LIMK1 (0.35) CYP1A2LIMK1CDK5CDK5R1PIK3CA
SCHEMBL25663148 0.82 LIMK1 (0.38) LIMK1CDK5CDK5R1PIK3CAHTR2C
SCHEMBL25663159 0.82 NPC1 (0.35) LIMK1CDK5CDK5R1PIK3CAHTR2C
SCHEMBL25663489 0.82 LIMK1 (0.35) LIMK1CDK5CDK5R1PIK3CAHTR2C
SCHEMBL25663149 0.81 LIMK1 (0.40) LIMK1CDK5CDK5R1PIK3CAPIK3CD
SCHEMBL25663150 0.80 LIMK1 (0.39) LIMK1CDK5CDK5R1PIK3CAHTR2C
SCHEMBL25663151 0.80 LIMK1 (0.35) LIMK1CDK5CDK5R1PIK3CAHTR2C
SCHEMBL25663157 0.80 LIMK1 (0.35) LIMK1CDK5CDK5R1PIK3CAHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 CYP1A2 336/4885LIMK1 1044/4885CDK5 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback